April 21, 2022 -- Purigen Biosystems has entered into a distribution agreement with GC biotech in support of its automated Ionic Purification System. The agreement gives GC biotech rights in Europe to distribute, service, and support the purification system, in addition to microfluidics kits.
This technology will now be available for purchase in the Netherlands, Belgium, and Luxembourg through this agreement, which is designed to extend the capabilities of clinical and oncology researchers in these countries.
The Ionic Purification System works by extracting high yields of purified DNA and RNA from various samples, including cultured or sorted cells, as well as formalin-fixed, paraffin-embedded tissues.
The benchtop technology lyses samples to be loaded into the Ionic Fluidics Chip. The system then separates and isolates the nucleic acids by applying an electrical field to the chip using Purigen's isotachophoresis technology.
The rapid process produces high-yield extraction with minimal sample loss, fragmentation, or purification-induced bias. The system also requires very little hands-on time and adequately prepares nucleic acids for further analysis, including next-generation sequencing and qPCR.
Copyright © 2022 scienceboard.net
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Conferences
Connect
